Translational Research: Pre-Clinical Development
The pre-clinical development of a potential therapeutic agent involves the manufacturing and formal testing of ADMET properties in preparation for submission to a regulatory agency for human trials. Rigorous efficacy studies of a pre-clinical lead candidate may also be conducted. These processes require regulatory expertise in their design, good manufacturing practices (GMP) manufacturing, and good laboratory practice (GLP) toxicology studies as well as consideration of future clinical trial design.
Target AssayScreeningHits and
HitHit to LeadLead Series
NIDDK-Specific Funding Opportunities
- PA-17-131, Lead Optimization and Pre-Clinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (R41/R42, Small Business Technology Transfer Research Grant)
- PA-17-130, Lead Optimization and Pre-Clinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (R43/R44, Small Business Innovation Research Grant)
- Bridging Interventional Development Gaps (BrIDGs)
- Therapeutics for Rare and Neglected Diseases (TRND)
- Academic Drug Discovery Consortium
- NIDDK Small Business Programs
For additional information, please contact Dr. Aaron Pawlyk.